Menu

GlaxoSmithKline

GSK’s Shingrix receives positive opinion from the CHMP in Europe for the prevention of shingles in adults aged 50 and over

, ,

London, UK – 26 January 2018 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for Shingrix for the prevention of shingles (herpes zoster) and post-herpetic neuralgia (PHN), the most common and often painful shingles-related complication, […]

GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus

, , ,

LONDON, UK – September, 27 2017 – GSK announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus (SLE) who are inadequate responders to existing therapies. Benlysta is for use as an add-on therapy in autoantibody positive SLE patients. […]

Relvar Ellipta significantly improved asthma control in Salford Lung Study patients compared with their usual care

, , ,

Primary endpoint showed patients initiated with Relvar Ellipta had twice the odds of achieving an improvement in asthma control compared with patients continuing usual care. London – 05 May 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva Inc (NASDAQ: INVA) today announced positive results from the innovative Salford Lung Study (SLS) in asthma, carried out […]

GSK announces regulatory submission in Japan of its candidate vaccine for prevention of shingles

, , ,

Follows regulatory submissions in US, EU and Canada London UK – 18 April 2017 – GSK [LSE/NYSE: GSK] today announced that Japan Vaccine Co., Ltd., a joint venture of GlaxoSmithKline and Daiichi Sankyo Co., Ltd., submitted a New Drug Application in Japan seeking approval for the candidate shingles vaccine, Shingrix, for the prevention of herpes […]

UK Biobank, GSK and Regeneron announce largest gene sequencing initiative on world’s most detailed health database to improve drug discovery and disease diagnosis

, , ,

Groundbreaking UK/US initiative will deliver first data within a year London UK – 23 March 2017 – UK Biobank today announced a major research initiative with GSK and the Regeneron Genetics Center (RGC) to generate genetic sequence data from the 500,000 volunteer participants in the UK Biobank resource. The initiative will enable researchers to gain […]

GSK confirms closure of agreement to divest anaesthesia portfolio to Aspen

, , ,

London UK – 01 March 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the closure of an agreement with Aspen (JSE: APN) aligned with GSK’s strategy of simplification through focusing on core therapeutic areas. GSK has divested its anaesthesia portfolio to Aspen (excluding the US and Canada which had been previously divested) for £180m plus […]

Abbas Hussain to leave GSK

, , ,

London – 19 January 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Abbas Hussain, President, Global Pharmaceuticals has decided to leave the company. He has agreed with GSK that he will leave the company later this year. Abbas joined GSK in 2008 and has held roles of increasing responsibility within the company’s pharmaceutical business. […]

GSK confirms closure of agreement to divest non-core assets to Aspen

, , ,

AFRICA – 03 January 2017 – GlaxoSmithKline today announced the closure of one of its series of agreements with Aspen Pharmacare Holdings Limited (JSE: APN) and certain of its subsidiaries (“Aspen”), which were the subject of announcements by both companies on 12 September 2016. GSK and Aspen have terminated their collaboration in Sub-Saharan Africa and […]

1 2